Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP raised its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 48.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 103,004 shares of the medical research company's stock after purchasing an additional 33,793 shares during the period. Quantinno Capital Management LP's holdings in Agilent Technologies were worth $13,838,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of A. Czech National Bank lifted its position in shares of Agilent Technologies by 4.8% in the fourth quarter. Czech National Bank now owns 62,299 shares of the medical research company's stock valued at $8,369,000 after acquiring an additional 2,843 shares in the last quarter. Cooper Financial Group lifted its position in shares of Agilent Technologies by 6.8% in the fourth quarter. Cooper Financial Group now owns 1,833 shares of the medical research company's stock valued at $246,000 after acquiring an additional 116 shares in the last quarter. Miracle Mile Advisors LLC purchased a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $362,000. Rosenberg Matthew Hamilton lifted its position in shares of Agilent Technologies by 85.2% in the fourth quarter. Rosenberg Matthew Hamilton now owns 526 shares of the medical research company's stock valued at $71,000 after acquiring an additional 242 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in shares of Agilent Technologies by 5.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 28,456 shares of the medical research company's stock valued at $3,823,000 after acquiring an additional 1,343 shares in the last quarter.

Insider Activity

In related news, Director Daniel K. Podolsky sold 1,819 shares of the business's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05% decrease in their position. The disclosure for this sale can be found here.

Analyst Ratings Changes

Several equities analysts have recently weighed in on A shares. Barclays decreased their target price on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 10th. TD Cowen raised their target price on Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. Wells Fargo & Company reduced their price objective on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Jefferies Financial Group reduced their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Finally, Robert W. Baird reduced their price objective on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research report on Thursday, February 27th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $143.00.

Agilent Technologies Trading Up 1.2%

NYSE:A traded up $1.36 on Friday, reaching $113.76. The company's stock had a trading volume of 1,811,948 shares, compared to its average volume of 1,904,117. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $154.95. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm has a market cap of $32.43 billion, a price-to-earnings ratio of 26.15, a price-to-earnings-growth ratio of 3.21 and a beta of 1.27. The stock has a 50 day moving average price of $110.44 and a 200 day moving average price of $128.17.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The company had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.54 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were given a $0.248 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.87%. Agilent Technologies's dividend payout ratio is currently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.